Track the Interpace Diagnostics Group, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €39.9m. The latest transaction was filed on 5 February 2016 (Attribution). Among the most active insiders: Glorikian Harry. All data is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 251 of 29,065 companies
87.9
score / 100
Value
85
Quality
91
FCF yld14%
Earn yld62%
EV/EBITDA8.6x
ROE214%
Gross mgn62%
Net mgn63%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.